April 04,2007
Grassley Seeks Marketing and Safety Documents from Major Drug Maker
WASHINGTON — Sen. Chuck Grassley is asking the drug maker, Eli Lilly and Company, for information related to the risks and marketing of the anti-psychotic drug Zyprexa. Grassley made this request in response to allegations that the company downplayed safety risks and engaged in other improper marketing practices that may be jeopardizing patients’ health.
The text of Grassley’s letter can be found in the printer-friendly version of this news release.
###
Next Article Previous Article
Recent News
- Wyden Statement on Supreme Court Ruling to Restrict Emergency Room Care for Women
- Wyden Statement on HHS Watchdog Report on Lack of Oversight at Youth Residential Treatment Facilities
- Wyden Calls for Action to Stop PBM Middlemen from Flagrantly Flouting Medicare Rules that Protect Pharmacies
- Wyden Statement on Final Rules Promoting Good-Paying Clean Energy Jobs in America
- Wyden Statement at Finance Committee Hearing on Work and Social Security